Annex A. Science And Technology Objectives (STOs)
Army Science and Technology Master Plan (ASTMP 1997)

III.J.02. Vaccines for the Prevention of Malaria. By FY96, transition to advanced development a candidate blood stage Plasmodium falciparum vaccine to reduce incidence of severe clinical malaria by 70 percent. By FY97, transition a vaccine to prevent P. falciparum infection in 70 percent of immunized troops. By FY98, transition to advanced development a candidate blood stage Plasmodium vivax vaccine to protect 70 percent of immunized troops from vivax malaria.

Supports: Army Modernization Plan, Medical Annex O—Project, Sustain, and Protect the Force. The Medical Threat Facing a Force Projection Army (1994). Food and Drug Administration regulatory requirements.